Company News
Wockhardt Receives CDSCO Approval for ZAYNICH Antibiotic
Wockhardt Ltd. received CDSCO marketing authorization for its breakthrough antibiotic ZAYNICH® (Zidebactam/Cefepime) to treat complicated urinary tract infections.
ZAYNICH® demonstrated 89% efficacy i
